Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole effect on endometrial histology in disordered proliferative endometrium or simple hyperplasia
IRCT2012092310901N2Phase 3Completed
- Sponsor
- Women's Reproductive Health Research Center
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of letrozole in Simple Endometrial Hyperplasia, disordered proliferative endometrium (DPE) and Endometrial diseases, sponsored by Women's Reproductive Health Research Center. Primary endpoint: Change in endometrial histology. Started Aug 2012; status: completed.
02
Drugs
letrozole
03
Conditions
Simple Endometrial Hyperplasiadisordered proliferative endometrium (DPE)Endometrial diseases
Beyond the preview
Go deeper on IRCT2012092310901N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012092310901N2.